Entellus Medical, Inc.
(NASDAQ : ENTL)

( )
ENTL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.22%81.250.6%$442.95m
ISRGIntuitive Surgical, Inc.
-1.60%373.552.5%$340.28m
TMOThermo Fisher Scientific Inc.
0.81%189.481.0%$320.21m
ABTAbbott Laboratories
0.53%54.930.8%$285.86m
ALGNAlign Technology, Inc.
-2.00%233.666.3%$282.70m
BSXBoston Scientific Corporation
-1.05%25.501.1%$280.19m
BDXBecton, Dickinson and Company
-0.65%218.251.3%$239.97m
BCRC. R. Bard, Inc.
-0.23%332.031.6%$183.53m
EWEdwards Lifesciences Corporation
0.13%118.181.2%$181.59m
BAXBaxter International Inc.
0.13%64.131.7%$171.29m
SYKStryker Corporation
0.50%152.691.3%$164.48m
HOLXHologic, Inc.
2.65%43.821.7%$138.42m
ZBHZimmer Biomet Holdings, Inc.
0.12%113.521.7%$134.32m
XRAYDENTSPLY International Inc.
0.19%65.023.0%$112.88m
DXCMDexCom, Inc.
-5.01%58.458.7%$99.74m

Company Profile

Entellus Medical, Inc. is a medical technology company focused on the design, development and commercialization of products for the treatment of chronic sinusitis. Its XprESS family of products is used by ear, nose and throat, physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses. Entellus Medical was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Plymouth, MN.